Back
Terns Pharmaceuticals, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
64
TERN
Terns Pharmaceuticals, Inc.
Last Price:
$41.98
Seasonality Move:
-4.1%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiTerns Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Terns Pharmaceuticals, Inc. has on average historically risen by 147.2% based on the past 4 years of stock performance.
-
Terns Pharmaceuticals, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Terns Pharmaceuticals, Inc. Stock Undervalued?The current Terns Pharmaceuticals, Inc. [TERN] share price is $41.98. The Score for TERN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
TERN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Terns Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Terns Pharmaceuticals, Inc. has on average historically risen by 147.2% based on the past 4 years of stock performance.
Terns Pharmaceuticals, Inc. Stock Rating
Buy
64
Terns Pharmaceuticals, Inc. (TERN)
is a Buy
Is Terns Pharmaceuticals, Inc. overpriced?
-
Terns Pharmaceuticals, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Terns Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ternspharma.com
52-Week Data
52-Week High:
48.26
52-Week Low:
1.87
Prediction Charts
Market Cap:
3.8B
Price in USD:
41.98
Volume:
2.7M
Beta:
-0.24
Technical Analysis
SMA50:
21.40
SMA100:
14.21
SMA200:
8.88
52-Wk Change:
517.35%
Stock Predictions
-
Is Terns Pharmaceuticals, Inc. stock public?Yes, Terns Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Terns Pharmaceuticals, Inc. stock quote today?The Terns Pharmaceuticals, Inc. stock price is 41.98 USD today.
-
How to buy Terns Pharmaceuticals, Inc. stock online?You can buy Terns Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-28 | 28.99 | 28.11 | 29.00 | 28.11 |
| Dec-1 | 27.90 | 27.53 | 28.15 | 26.87 |
| Dec-2 | 27.79 | 25.79 | 27.90 | 25.67 |
| Dec-3 | 25.92 | 27.49 | 27.88 | 25.75 |
| Dec-4 | 27.22 | 27.13 | 28.17 | 26.53 |
| Dec-5 | 27.73 | 29.36 | 30.25 | 27.42 |
| Dec-8 | 31.53 | 40.23 | 45.00 | 30.12 |
| Dec-9 | 40.00 | 42.57 | 45.18 | 40.00 |
| Dec-10 | 42.52 | 44.61 | 48.26 | 42.34 |
| Dec-11 | 45.15 | 47.09 | 48.00 | 45.00 |
| Dec-12 | 46.98 | 45.00 | 47.13 | 44.50 |
| Dec-15 | 44.64 | 44.01 | 45.09 | 43.55 |
| Dec-16 | 44.09 | 42.92 | 45.17 | 42.24 |
| Dec-17 | 43.03 | 41.98 | 43.40 | 41.21 |
Terns Pharmaceuticals, Inc. Earnings
Terns Pharmaceuticals, Inc. Earnings Report: Per Share Terns Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Terns Pharmaceuticals, Inc. Forecast Revenue Growth
Terns Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Terns Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.12 per share.
* Terns Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.